In Brief: Cold-Eeze cold relief lozenges
This article was originally published in The Tan Sheet
Executive Summary
Cold-Eeze cold relief lozenges: Quigley Corp. says it will complete initial expansion of its Doylestown, Penn. manufacturing facility by mid-December to fulfill a $3.5 mil. backlog of purchase orders for the homeopathic cold product. "New purchase orders...have reached $500,000 per week," Quigley says Dec. 3, and the newly expanded facility will allow the firm to maintain production of "over $1 mil. of product per week." Further expansions are already planned. Cold-Eeze was studied by the Cleveland Clinic and found to "significantly shorten" the duration of cold symptoms in 100 test subjects ("The Tan Sheet" July 15, p. 19). The product is sold through national discount food and drug chains such as Walgreen's and Kmart...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning